Home > Boards > US Listed > Medical - Equipment > BrainsWay (BWAY)

BRAINSWAY LTD/S (NASDAQ:BWAY) EARNINGS INFORMATION (NASDAQ:BWAY)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
midastouch017 Member Profile
 
Followed By 125
Posts 25,541
Boards Moderated 9
Alias Born 02/07/04
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/3/2021 9:31:09 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 6/3/2021 9:29:07 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/2/2021 8:00:58 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/1/2021 8:01:06 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/24/2021 8:01:03 AM
Brainsway EPS misses by $0.03, beats on revenue Seeking Alpha - 5/20/2021 8:09:26 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/20/2021 8:01:04 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/5/2021 8:00:57 AM
Tender Offer Statement by Issuer (sc To-i) Edgar (US Regulatory) - 5/4/2021 9:29:32 AM
BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month GlobeNewswire Inc. - 5/4/2021 9:02:00 AM
BrainsWay launches noninvasive treatment for smoking addiction Seeking Alpha - 4/29/2021 9:10:50 AM
BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers GlobeNewswire Inc. - 4/29/2021 9:03:00 AM
RIOT, MARA, OCGN and MVIS among notable premarket gainers Seeking Alpha - 4/26/2021 8:21:35 AM
BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment Seeking Alpha - 4/26/2021 7:43:06 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/26/2021 7:30:54 AM
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder GlobeNewswire Inc. - 4/26/2021 7:30:00 AM
BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS) GlobeNewswire Inc. - 4/14/2021 9:03:00 AM
Brainsway EPS beats by $0.03, beats on revenue Seeking Alpha - 3/24/2021 4:24:50 PM
BrainsWay Ltd. Announces Closing of $45.2 Million Underwritten Public Offering of American Depositary Shares Including Full E... GlobeNewswire Inc. - 3/1/2021 7:00:00 AM
BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares GlobeNewswire Inc. - 2/23/2021 8:30:00 AM
BrainsWay readies ADS offering Seeking Alpha - 2/22/2021 4:06:39 PM
BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 2/22/2021 4:02:00 PM
BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales GlobeNewswire Inc. - 2/16/2021 7:30:00 AM
BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results GlobeNewswire Inc. - 2/16/2021 7:00:00 AM
BrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC GlobeNewswire Inc. - 1/25/2021 8:00:00 AM
midastouch017   Sunday, 06/14/20 03:44:50 AM
Re: None
Post # of 29 
BRAINSWAY LTD/S (NASDAQ:BWAY) EARNINGS INFORMATION (NASDAQ:BWAY)

BRAINSWAY LTD/S last posted its earnings data on March 23rd, 2020. The reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02. The firm earned $6.29 million during the quarter, compared to analyst estimates of $6.25 million. BRAINSWAY LTD/S has generated ($0.50) earnings per share over the last year. BRAINSWAY LTD/S has confirmed that its next quarterly earnings report will be published on Wednesday, June 24th, 2020. BRAINSWAY LTD/S will be holding an earnings conference call on Wednesday, June 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

HOW HAS BRAINSWAY LTD/S’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NASDAQ:BWAY)
BRAINSWAY LTD/S’s stock was trading at $8.19 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BWAY stock has decreased by 10.6% and is now trading at $7.32. View which stocks have been most impacted by Coronavirus.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences